Compare StocksABBV vs PH

AbbVie Inc. (ABBV) vs Parker-Hannifin Corporation (PH): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. PH is overvalued at $977, with an intrinsic value of $665 and a margin of safety of -47%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
PH
Parker-Hannifin Corporation
$976.53

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
PH
  • Parker-Hannifin Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Parker-Hannifin Corporation scores 84/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
  • Free cash flow has grown at a 14.7% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
PH
  • FCF yield of 2.3% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • PEG ratio of 3.82 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • 28 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
ABBV
PH
Valuation
N/A
Free Cash Flow
$2.77B
N/A
FCF Yield
2.25%
70.89
Trailing P/E
35.97
15.41
Forward P/E
28.63
Quality & Moat
27.60%
ROIC
14.75%
N/A
ROE
24.84%
72.79%
Gross Margin
37.44%
0.41
PEG Ratio
3.82
Balance Sheet Safety
N/A
Net Debt / Equity
0.62
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
1.66
2.76%
Dividend Yield
0.82%
ABBV: 5Ties: 1PH: 2
ABBVPH

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PH

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PH
$12.10
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$6.11B
Δ Market Cap
+$73.94B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PH
47.0% Overvalued
Price is 47.0% above estimated fair value
Current Price: $976.53
Fair Value: $664.52
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

PH

What growth rate is the market pricing in at $977?

+14.5%
Market-Implied Owner Earnings Growth
Standard FCF implies +19.6%

The market implies +14.5% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +19.6%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PH
84/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PH
-2.48
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PH
Insiders 0.2%Institutions 90.8%Retail & Other 9.0%
No. of Institutional Holders2,520
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PH
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PH
0
Sells (3M)
28
Sells (12M)
Total value (12M): $46.28M
BRACHT BEREND
Officer
$1.13M
@ $1002.13 · 2026-02-13
BENDALI RACHID
Officer
$414,777
@ $1006.74 · 2026-02-13
SCOTT PATRICK M.
Officer
$818,889
@ $983.06 · 2026-02-12
HART MARK J
Officer
$2.83M
@ $1009.12 · 2026-02-12
GENTILE THOMAS C.
Officer
$1.33M
@ $1001.51 · 2026-02-12
ROSS ANDREW D.
President
$4.66M
@ $999.00 · 2026-02-11
LEOMBRUNO TODD M.
Chief Financial Officer
$2.07M
@ $1002.34 · 2026-02-11
PARMENTIER JENNIFER A
Chief Executive Officer
$4.69M
@ $996.66 · 2026-02-11
BRACHT BEREND
Officer
$1.38M
@ $946.48 · 2026-02-02
JACOBSON MATTHEW A.
Officer
$535,766
@ $949.94 · 2026-02-02
PAREL DINU JOHN
Chief Technology Officer
$1.25M
@ $950.05 · 2026-02-02
GENTILE THOMAS C.
Officer
$2.24M
@ $941.31 · 2026-01-30
IVES ANGELA R
Officer
$1.02M
@ $952.30 · 2026-01-30
ROSS ANDREW D.
Chief Operating Officer
$2.23M
@ $894.81 · 2025-12-11
BRACHT BEREND
Officer
$3.03M
@ $864.58 · 2025-11-12
BENDALI RACHID
Officer
$1.23M
@ $852.99 · 2025-11-12
REIDY JAY
Officer
$337,675
@ $863.62 · 2025-11-12
VERRIER JAMES R.
Director
$1.13M
@ $750.00 · 2025-09-02
LEONTI JOSEPH R.
General Counsel
$3.47M
@ $750.84 · 2025-08-25
PAREL DINU JOHN
Chief Technology Officer
$817,477
@ $741.14 · 2025-08-12
BRACHT BEREND
Officer
$202,506
@ $728.44 · 2025-08-08
SCOTT PATRICK M.
Officer
$1.15M
@ $729.45 · 2025-08-08
JACOBSON MATTHEW A.
Officer
$421,510
@ $733.06 · 2025-08-08
MALONE ROBERT W
Officer
$1.65M
@ $730.66 · 2025-08-08
ROSS ANDREW D.
President
$3.20M
@ $732.66 · 2025-08-08
HART MARK J
Officer
$1.65M
@ $730.22 · 2025-08-08
GENTILE THOMAS C.
Officer
$826,524
@ $729.50 · 2025-08-08
IVES ANGELA R
Officer
$589,162
@ $727.36 · 2025-08-08
REIDY JAY
Officer
$335,783
@ $675.62 · 2025-05-19
REIDY JAY
Officer
$93,056
@ $620.37 · 2025-05-02
CZAJA MARK T.
Chief Technology Officer
$266,948
@ $711.86 · 2025-01-31
BRACHT BEREND
Officer
$1.08M
@ $699.29 · 2024-11-06
MALONE ROBERT W
Officer
$2.76M
@ $700.24 · 2024-11-06
ROSS ANDREW D.
Chief Operating Officer
$3.43M
@ $706.04 · 2024-11-06
GENTILE THOMAS C.
Officer
$1.70M
@ $701.16 · 2024-11-06
PAREL DINU JOHN
Officer
$1.23M
@ $699.39 · 2024-11-06
PARMENTIER JENNIFER A
Chief Executive Officer
$3.46M
@ $704.69 · 2024-11-06
HART MARK J
Officer
$2.79M
@ $705.40 · 2024-11-06
VERRIER JAMES R.
Director
$825,981
@ $635.37 · 2024-11-04
LEONTI JOSEPH R.
General Counsel
$3.71M
@ $631.04 · 2024-11-01
IVES ANGELA R
Officer
$118,773
@ $635.15 · 2024-11-01
BRACHT BEREND
Officer
$503,982
@ $592.92 · 2024-08-26
PARMENTIER JENNIFER A
Chief Executive Officer
$1.55M
@ $588.59 · 2024-08-22
ROSS ANDREW D.
President
$1.90M
@ $588.58 · 2024-08-16
BENDALI RACHID
Officer
$1.04M
@ $574.86 · 2024-08-14
GENTILE THOMAS C.
Officer
$583,536
@ $567.09 · 2024-08-09
PAREL DINU JOHN
Chief Technology Officer
$807,685
@ $571.61 · 2024-08-09
HART MARK J
Officer
$1.17M
@ $566.23 · 2024-08-09
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PH
FearGreed
😏Greed(65/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
PH
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (65)
View ABBV Full AnalysisView PH Full Analysis

Frequently Asked Questions: ABBV vs PH

Is AbbVie Inc. or Parker-Hannifin Corporation more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -40.7% margin of safety (intrinsic value $178 vs. price $251), compared to PH's -47.0% margin of safety (intrinsic $665 vs. $977).

Which stock has a wider economic moat, AbbVie Inc. or Parker-Hannifin Corporation?

PH scores 84/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. PH scores 6.4 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Parker-Hannifin Corporation?

ABBV earns 27.6% ROIC versus PH's 14.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Parker-Hannifin Corporation's?

PH's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). PH has raised its dividend for 3 consecutive years.